Subsequently, transgenic mice with defective TLR4 signaling causing them to be hyporesponsive to lipopolysaccharide (LPS) were found to exhibit a significantly accelerated rate of prion disease development in comparison to their wild-type counterparts [11]. The gene discussed is TLR4; the disease is prion disease.